Ludger Limited

Ludger Limited is an SME in Abingdon, United Kingdom that has taken part in 12 EU-funded projects since 2008, receiving €4.7M in EU funding.

EU funding received€4.7M
EU projects12
As coordinator0
Running now4
First EU project2008
Latest project2027
CountryUnited Kingdom
EU registration (PIC)998582700
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Ludger Limited's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€1.8M · 4 projects
  • Horizon Europe€1.4M · 4 projects
  • Horizon 2020€1.4M · 4 projects

Projects

12 EU-funded projects, newest first. Each links to the official record.

  • GlyCaBiotaPartner

    Doctoral Training Network on Glycan–Cancer–Microbiota Interactions for Therapeutic and Diagnostic Innovation in Colorectal cancer

    Horizon Europe · 2027–2030 · Project on CORDIS ↗

    €349ktheir share
  • GLYCOCALYXPartner

    Self-organisation and barrier functions of the mammalian glycocalyx – Training glycoscientists across disciplines and borders to stimulate new approaches, understanding and biomedical applications

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €349ktheir share
  • INTERCEPTPartner

    Verification and validation of a biomarker panel that identifies individuals at high risk to develop Crohn’s disease allowing INTERCEPTION of full-blown disease development

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €723ktheir share
  • GlycanTriggerAssociated partner

    GLYCANS AS MASTER TRIGGERS OF HEALTH TO INTESTINAL INFLAMMATION TRANSITION

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

  • NanoCarbPartner

    Glyco-Nanoparticles for Applications in Advance Nanomedicine

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €303ktheir share
  • A4BPartner

    Analytics for Biologics

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

    €273ktheir share
  • GlySignPartner

    Exploitation of Glycosylation Signatures for Precision Medicine

    Horizon 2020 · 2016–2020 · Project on CORDIS ↗

    €547ktheir share
  • GlyCoCanPartner

    Exploiting Glycosylation of Colorectal Cancer for the development of improved diagnostics and therapeutics

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €273ktheir share
  • GLYCOPARPartner

    Parasite glycobiology and anti-parasitic strategies

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €256ktheir share
  • IBD-BIOMPartner

    Diagnostic and prognostic biomarkers for inflammatory bowel diseaseIBD-BIOM

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €393ktheir share
  • HIGHGLYCANPartner

    Methods for high-throughput (HTP) analysis of protein glycosylation

    FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

    €1.0Mtheir share
  • EUROGLYCOARRAYSPartner

    Development of carbohydrate array technology to systematically explore the functional role of glycans in healthy and diseased states

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €186ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • adverse drug reactions
  • amines
  • autoimmune diseases
  • biophysics
  • carbohydrates
  • coating and films
  • colorectal cancer
  • diabetes
  • electrolysis
  • genetics
  • immunology
  • inflammatory bowel disease
  • mass spectrometry
  • microscopy

Ludger Limited is listed on EUACC

See the startup profile for its product, team and what it is looking for.

Open the startup profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime